Fresenius Medical Care AG & Co. KGAA (ETR:FME) Given a €92.00 Price Target at Credit Suisse Group

Credit Suisse Group set a €92.00 ($108.24) price objective on Fresenius Medical Care AG & Co. KGAA (ETR:FME) in a research note issued to investors on Monday, November 6th. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently issued reports on the stock. Morgan Stanley set a €90.00 ($105.88) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a buy rating in a research note on Friday, September 15th. Nord/LB set a €93.00 ($109.41) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a buy rating in a research note on Thursday, November 2nd. Goldman Sachs Group Inc set a €97.00 ($114.12) price objective on shares of Fresenius Medical Care AG & Co. KGAA and gave the stock a buy rating in a research note on Friday, September 29th. J P Morgan Chase & Co set a €106.40 ($125.18) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a report on Wednesday, August 2nd. Finally, Berenberg Bank set a €95.60 ($112.47) target price on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a buy rating in a report on Tuesday, September 5th. One analyst has rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of €89.05 ($104.77).

Fresenius Medical Care AG & Co. KGAA (ETR:FME) traded down €0.15 ($0.18) during trading on Monday, reaching €82.35 ($96.88). 376,776 shares of the company were exchanged, compared to its average volume of 515,915. Fresenius Medical Care AG & Co. KGAA has a 1-year low of €71.49 ($84.11) and a 1-year high of €89.22 ($104.96).

TRADEMARK VIOLATION NOTICE: “Fresenius Medical Care AG & Co. KGAA (ETR:FME) Given a €92.00 Price Target at Credit Suisse Group” was reported by BBNS and is owned by of BBNS. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://baseballnewssource.com/markets/credit-suisse-group-reiterates-92-00-price-target-for-fresenius-medical-care-ag-co-pref-fme/1761522.html.

About Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.